Mohammad, Baby Boy .
HRN: 23-53-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/06/2024
05/13/2024
IV
180 Mg
Q6
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes